FNMA Company info 08/11/2014 23:18:30 $FNMA And the clowns

New Post Public Reply Private Reply Replies (0) Message Board
Jake13
FNMA Company info 08/11/2014 23:18:30 $FNMA
And the clowns at W S J seem to think that these types of profits are irrelevant?

What a bunch of jokers IMO.

No wonder nobody reads their crap anymore they don't even make the top 20.
http://www.news.nettop20.com
Minium over a Billy per quarter fricken outstanding. $$FNMA$$
That's what i'm thinking. Who knows how many shares he has now. it's been 4+ months since he bought those shares from Berkowitz.
That's what it seems like. Who is the next whale? one we know of or one we don't.
BIG BOYS NOT MESSING AROUND...FNMA FMCC $$$



FY 2013 - The leaner, meaner, stronger than ever FNMA continues to thrive and expand tactfully.


Read what CEO Timothy Mayopoulos has to say;

http://www.fanniemae.com/progress/2013-Year-i...index.html
Over 3 trillion to the mortgage market since 2009 is huge!!! Go FNMA!!!! Free us soon!!! FNMA $$$$$$
And since 2009 FNMA has provided over 3 Trillion in liquidity to the mortgage market. Fact.
http://www.fanniemae.com/progress/index.html
if this company's profits were to fall over 50 percent (which they won't) they would STILL make over a billion in profits. They'd still be one of America's most profitable companies... these articles are hysterical, and those crying the sky is falling have other motives. It's easy to sway stupid
U been around a while aint ya?
CARL SHAKING THE TREE HARD...FNMA FMCC
Oh, I dont even know how much I paid for my shares anymore. You could probably say they are all free, but I am sure somebody paid me to buy them now, lol. Dunno anymore as I have traded her in and out so many times. I have even shorted against my owned shares before to help my trading ADD while on pullbacks. This baby is a slot machine for tech traders. Supports and resistances well defined. 3.76 isnt really a stop loss in the fact that I will become negative or anything. I keep it in mind because I am pretty sure if we close under that support, we will see 3 again. I hope that doesnt happen because it breaks our trend on the daily and possibly starts setting up a descender. I stand firm in my belief this decline is a combination of broad market pessimism and some heavy handed traders or investors accumulating and taking advantage of the stagnant volume. MFI is close to oversold. RSI is close to oversold. MACD does not really look too hot, but TRIX is getting negative. Looks like a bounce ready to happen when this goes lower. (3.76).
So true! We are still way undervalued here! Go FNMA!!!! $$$$$$$$$ free us now!!!
Whatever. The mm's use the info to manipulated the stock price for their benefit in the short run.
I don't know that there is panic but they try with these poorly written articles full of half truths.
What is the source of this so called panic?
Crap, this is a co-ordinated effort to scare off investors and induce panic selling.
You know the truth just like I do. Even without any extraordinary income they are still making enough to where fair value is 10 to 20 times what it is today, minimum!
Right but the facts are worrisome, the profits are becoming smaller even with a few legal settlements, as the fhfa is shrinking the foot print, soon the legal settlements will end and the profits will be even smaller. It's reasonable to think that shareholders would be interested in a company that makes billions of dollars but would lose interest quickly if it can't make billions anymore.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 6

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 7

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 14

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 6

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 3

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading

Top 5 Most Recently Viewed Articles

CeraVe Marks 20 Years of Groundbreaking Skincare Innovations

Updated Category News Views 259

CeraVe's Celebrated Journey in Skincare CeraVe is making waves as it marks an impressive milestone: 20 years of dedicated skincare science. Launching with the mission to nurture and restore skin health, the brand has garnered an extensive following of both customers and dermatology professionals worldwide. By focusing on skin barrier health and utilizing innovative...

Continue Reading
Exploring Novartis' Latest Innovations in Hematology and Oncology

Updated Category News Views 320

Novartis Pioneers Innovations in Hematology and Oncology Basel – Novartis has been making headlines with groundbreaking data presented at major medical meetings, including the esteemed American Society of Hematology (ASH) Annual Meeting and the San Antonio Breast Cancer Symposium (SABCS). This year, Novartis is showcasing over 70 abstracts with significant findings that...

Continue Reading
Sustainable Green Team Reveals Patents for Eco-Innovation

Updated Category News Views 189

Innovative Patents by Sustainable Green Team Sustainable Green Team, Ltd. (OTC: SGTM) is making significant strides in environmental responsibility by filing an impressive portfolio of 20 U.S. provisional patent applications. This initiative marks the unveiling of the SGTM 20-Patent Fortress™, consolidating the company's dedication to revolutionizing waste management...

Continue Reading
SSL's C2PA Game Changer: Authenticity or Just Hype?

Updated Category News Views 172

SSL just dropped a bombshell on the digital content authenticity scene. On February 18, 2026, they announced themselves as the first publicly trusted certificate authority to roll out production-ready C2PA-conformant certificates. But what’s behind all this noise? Desks are buzzing about whether this marks a real breakthrough against deepfakes and misinformation or if...

Continue Reading
MiMedia's Innovations at Mobile World Congress Excite Investors

Updated Category News Views 95

MiMedia Partners with Orbic at Mobile World Congress MiMedia Holdings Ltd. is excited to announce its collaboration with Orbic, a prominent US OEM, to develop and market the new line of rugged devices under the Caterpillar brand. This partnership was highlighted during the recently attended Mobile World Congress conference, where innovative trends within the tech industry...

Continue Reading